Takeda Pharmaceutical Company Limited expected to post earnings of JPY134.54 a share - Earnings Preview

What happened

Takeda Pharmaceutical Company Limited is expected to report results on October 29 for the period ending September 30 2026. Two analysts expect revenue to rise 5.6% to JPY1.175 trillion and earnings of JPY134.54 a share.

Confirmed

Global impact / market context

Analyst estimates give investors a benchmark for judging Takeda's results. A 5.6% revenue increase suggests the company is expected to grow sales. If actual results miss the JPY134.54 per share estimate, the stock could come under pressure because investors value future profits.

Analyst inference

The average analyst rating on Takeda shares is buy, with three buy ratings and no hold or sell ratings. The median 12-month price target of $21.90 is 7.2% above the last closing price of $20.43, suggesting analysts expect modest gains.

Analyst inference

What to watch

1. Takeda reports results on October 29 for the period ending September 30 2026. Watch whether actual revenue reaches the expected JPY1.175 trillion and whether earnings per share hit JPY134.54. Confirmed
2. Investors could compare the actual revenue growth with the expected 5.6% increase. A slower rise would suggest weaker demand, while a faster rise would support the buy ratings analysts currently hold. Proposed
3. Watch whether the mean earnings estimate stays unchanged before the report. Any revisions would signal shifting analyst views on Takeda's costs and profit per sale. Analyst inference

Evidence

• Original source link unavailable